Sign in
4

Changes in Ownership

Candel Therapeutics, Inc. Filed Acc 0000950170-25-090193

Chief Financial Officer acquired 5,353 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Schoch Charles Chief Financial Officer 2025-06-25 Grant or award +5,353 $4.67 $24,999 43,391 D: show line 1 in the form
Loading xslF345X05/ownership.xml…